1. Home
  2. FNWD vs RCEL Comparison

FNWD vs RCEL Comparison

Compare FNWD & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWD
  • RCEL
  • Stock Information
  • Founded
  • FNWD 1994
  • RCEL N/A
  • Country
  • FNWD United States
  • RCEL United States
  • Employees
  • FNWD N/A
  • RCEL N/A
  • Industry
  • FNWD Savings Institutions
  • RCEL Medical/Dental Instruments
  • Sector
  • FNWD Finance
  • RCEL Health Care
  • Exchange
  • FNWD Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • FNWD 137.3M
  • RCEL 140.5M
  • IPO Year
  • FNWD N/A
  • RCEL N/A
  • Fundamental
  • Price
  • FNWD $31.85
  • RCEL N/A
  • Analyst Decision
  • FNWD Buy
  • RCEL Strong Buy
  • Analyst Count
  • FNWD 1
  • RCEL 4
  • Target Price
  • FNWD $34.00
  • RCEL $13.75
  • AVG Volume (30 Days)
  • FNWD 17.8K
  • RCEL 1.3M
  • Earning Date
  • FNWD 10-23-2025
  • RCEL 11-06-2025
  • Dividend Yield
  • FNWD 1.51%
  • RCEL N/A
  • EPS Growth
  • FNWD N/A
  • RCEL N/A
  • EPS
  • FNWD 1.24
  • RCEL N/A
  • Revenue
  • FNWD $63,780,000.00
  • RCEL $74,884,000.00
  • Revenue This Year
  • FNWD N/A
  • RCEL $22.92
  • Revenue Next Year
  • FNWD $7.77
  • RCEL $37.07
  • P/E Ratio
  • FNWD $25.64
  • RCEL N/A
  • Revenue Growth
  • FNWD N/A
  • RCEL 38.32
  • 52 Week Low
  • FNWD $26.12
  • RCEL $3.60
  • 52 Week High
  • FNWD $33.50
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • FNWD 53.93
  • RCEL 54.48
  • Support Level
  • FNWD $31.53
  • RCEL $5.03
  • Resistance Level
  • FNWD $32.97
  • RCEL $5.64
  • Average True Range (ATR)
  • FNWD 0.90
  • RCEL 0.34
  • MACD
  • FNWD -0.18
  • RCEL 0.01
  • Stochastic Oscillator
  • FNWD 18.48
  • RCEL 49.00

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: